News
| 10:25 AM | @stevenplace $NVAX..$DNDN..$PCX by Winger |
| Feb 10 | $NVAX.. $10 by year end????.. When will the big boys take notice and gobble them up?? by Winger |
| Feb 10 | NOVAVAX to Present at the 14th Annual Bio CEO & Investor Conference GlobeNewswire |
| Feb 08 | new strain of flu containing 7 genes have been circulating in pigs been confirmed in a dozen cases in U.S $NVAX $BCRX http://stks.co/2J6k by lovedmarket |
| Feb 07 | 3 confirmed cases of the H1N1 virus in California Prison $BCRX $NVAX http://stks.co/2HgT by lovedmarket |
| Feb 06 | RT @Sal22Mazzo Posted Jan 26th $NVAX. in and out is not my style. time frame is 6 months buy now instead of when every1 is tweetin about it by Sal22Mazzo |
| Feb 06 | RT @Betacap $NVAX $BCRX 58 dead with 2,815 confirmed to have flu in Mexico. http://stks.co/2GQG by lovedmarket |
| Feb 03 | @Sal22Mazzo too late! I sold $NVAX for scratch. still holding 2000 in IRA from 1.35 though. by Rodg3r |
| Feb 03 | @Rodg3r $nvax... please dont sell... hold this for the run up by Sal22Mazzo |
| Feb 03 | @johnwelshtrades $nvax. just buy and hold it.. if u did that u would be making money by Sal22Mazzo |
| Feb 01 | Novavax (NVAX) Appoints Mervyn Hamer as VP of Manufacturing Street Insider |
| Feb 01 | NOVAVAX Appoints Mervyn L. Hamer, Vice President of Manufacturing GlobeNewswire |
| Jan 30 | 7 Best-Performing, Heavily Traded Biotechs Of The Year Under $10 |
| Jan 26 | Past Bouncers And Others Biotech Plays Ready To Move |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Novavax is down N/A over the last year vs S&P 500 Total Return up N/A, BioCryst Pharmaceuticals down N/A, and Hemispherx Biopharma down N/A.
- NVAX Total Returns
- ^SPXTR Total Returns
- BCRX Total Returns
- HEB Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these NVAX related companies
Pro Strategies Featuring NVAX
Did Novavax make it into our Pro Portfolio Strategies?
NVAX Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other NVAX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NVAX | 1.35 | -0.06 | -4.26% | 155.41M |
| CDII | 0.93 | 0.01 | 1.09% | 37.50M |
| CNBC | 9.98 | -0.05 | -0.50% | 162.57M |
| SWHC | 5.16 | -0.10 | -1.90% | 333.39M |
| HEB | 0.37 | 0.04 | 10.45% | 50.13M |
| ACAS | 8.69 | 0.15 | 1.76% | 3.00B |
| BEST | 0.62 | -0.11 | -15.07% | 17.07M |
| ATPG | 6.69 | -0.14 | -2.05% | 345.34M |
| JRCC | 6.38 | -0.51 | -7.40% | 227.13M |
| FMCN | 23.47 | -0.76 | -3.14% | 3.40B |
